Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

Fig. 3

Clinical response to IVIG therapy and its correlation with plasma PGE2. Correlation between the clinical response (MRC score) at different time points (weeks 1, 2, and ≥4) after initiation of IVIG therapy and the fold changes in plasma PGE2 level at week 1. Each symbol represents individual patient. r = Pearson correlation. p = statistical significance

Back to article page